INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 5,341.16 Million by 2030 | 9.0 % | Asia Pacific |
| by Type | by Source | by Mode of Delivery | by End User | by Region |
|---|---|---|---|---|
|
|
|
|
|
SCOPE OF THE REPORT
Market Overview
The global Marine-derived pharmaceuticals market is anticipated to grow from USD 2,922.11 Â Million in 2023 to USD 5,341.16 Million by 2030, at a CAGR of 9.0 % during the forecast period.
Marine – derived pharmaceuticals, also known as marine drugs or marine-derived compounds, are pharmaceutical products and drug candidates that are derived from marine organisms, primarily from the world’s oceans. These marine organisms can include various forms of marine life, such as algae, sponges, corals, mollusks, and microorganisms like bacteria and fungi. The pharmaceutical industry has shown a rising interest in exploring marine-derived compounds for drug discovery and development due to the unique chemical structures and bioactive properties found in these organisms. Marine functional ingredients have changed in unique and often harsh environments, leading to the development of diverse and bioactive compounds as a defense mechanism. These mixtures can have various pharmacological possessions, including antimicrobial, anti-inflammatory, and antitumor activities. Marine-derived compounds are a valued source of novel drug candidates and lead compounds for pharmaceutical research. They offer the potential for developing new medications to treat various diseases and conditions.
The world’s oceans are rich in biodiversity, and marine organisms produce a vast array of unique chemical compounds. Many of these compounds have not been found in terrestrial organisms. The potential for determining new and previously unknown compounds with therapeutic properties drives research and investment in marine-derived pharmaceuticals. Compounds originating from marine sources have shown bioactive characteristics with possible medical uses. These substances have potential for treating a number of illnesses, such as cancer, infectious diseases, neurological conditions, and more. Interest and investment in them have increased as a result of their success in preclinical and clinical investigations. The emergence of bacteria and illnesses resistant to antibiotics has created an urgent need for innovative therapeutic options. Pharmaceuticals derived from marine sources provide novel compounds that could be useful against resistant strains and provide solutions to medication resistance issues. Partnership between pharmaceutical companies, biotech firms, academic institutions, and marine biologists has extended the scope of bioprospecting efforts. This collaborative approach has led to a more systematic and rigorous search for marine-derived drug candidates.
Marine-derived Pharmaceuticals Market Report Scope and Segmentation
| ATTRIBUTE | DETAILS |
| Study period | 2020-2030 |
| Base year | 2022 |
| Estimated year | 2023 |
| Forecasted year | 2023-2030 |
| Historical period | 2019-2021 |
| Unit | Value (USD Million) (Kilotons) |
| Segmentation | By Type, Source, Mode of Delivery, End User and Region |
| By Type | o  Phenol
o  Steroid o  Ether o  Peptide o  Mollusk o  Sponge o  Tunicate o  Others |
| By Source | o  Algae
o  Invertebrates o   Microorganisms |
| By Mode of Delivery | o  Anti-microbial
o  Anti-tumor o  Anti-cardiovascular o  Anti-viral o  Anti-inflammatory o  Others |
| By End User | o  Hospitals
o  Retail Pharmacy o  Online Pharmacy o  Others |
| By Region
 |
o  North America
o  Asia Pacific o  Europe o  South America o  Middle East Asia & Africa |
Marine-derived Pharmaceuticals Market Segmentation Analysis
Marine-derived pharmaceuticals market is divided into 5 segments, type, source, mode of delivery, end user and region. By type the market is bifurcated into Phenol, Steroid, Ether, Peptide, Mollusk, Sponge, Tunicate, Others. By source the market is bifurcated into Algae, Invertebrates, Microorganisms. By mode of delivery the market is bifurcated into Anti-microbial, Anti-tumor, Anti-cardiovascular, Anti-viral, Anti-inflammatory and Others. By end user the market is bifurcated into Hospitals, Retail Pharmacy, Online Pharmacy, Others.
Based on source Invertebrates segment dominating in the marine derived pharmaceuticals market. Many invertebrates have developed complex and potent chemical defense mechanisms to protect themselves from predators and pathogens in their often competitive marine environments. These defense compounds can have medicinal potential. Invertebrates’ bioactive compounds often exhibit promising biological activity, such as antimicrobial, anti-inflammatory, and anticancer properties, which makes them attractive for drug discovery. Invertebrate-derived compounds can have unique and structurally complex chemical compositions not found in terrestrial sources. These unique structures can lead to the development of novel drugs. Invertebrates’ unique metabolic processes contribute to the creation of diverse compounds with potential pharmaceutical Mode of Deliverys. Researchers have devoted significant efforts to exploring and studying invertebrate organisms from various marine habitats worldwide, leading to the discovery of numerous bioactive compounds. Some invertebrate-rich marine habitats are protected, making them ideal locations for sustainable collection and research without harming delicate ecosystems. Several marine-derived drugs from invertebrates have advanced through preclinical and clinical trials and received regulatory approvals for various medical indications. These successes have further propelled interest in this segment. The pharmaceutical industry and researchers are increasingly focusing on ethical and sustainable practices to protect invertebrate species and marine ecosystems. International collaboration among research institutions, pharmaceutical companies, and marine conservation organizations has expanded the reach of marine-derived pharmaceutical research.
Based on end user Online Pharmacy segment dominating in the Marine Derived Pharmaceuticals Market. Online pharmacies often have a broader selection of pharmaceutical products, including niche or specialty medications. If marine-derived pharmaceuticals are considered a specialty or niche product, online platforms may be better equipped to offer them. Some individuals prefer the privacy of online ordering for medications, especially for sensitive or potentially stigmatized conditions. Online pharmacies can provide a discreet way to obtain medications. Online platforms typically offer extensive information about medications, including their uses, side effects, and interactions. This educational aspect can be beneficial when introducing innovative products like marine-derived pharmaceuticals. Online pharmacies have the potential to reach a global customer base, which is especially advantageous for unique or specialized pharmaceuticals like those derived from marine sources. These products may have a broader market appeal beyond local or regional markets. Reputable online pharmacies often adhere to strict regulatory standards, ensuring the safety and quality of the products they offer. This is crucial for pharmaceuticals, including marine-derived ones. Online platforms typically offer price transparency, allowing customers to compare costs and find the best deals. This can be essential for cost-sensitive patients.
Market dynamics
Marine-derived Pharmaceuticals have anti-infective properties, which is a key trend in the market. Researchers are evaluating the potential of peptides from marine sources as anti-infective agents. Marine-derived Pharmaceuticals are specific fragments of protein that act as sources of nitrogen and amino acids. They have various potential physiological functions. Fish, algae, crabs, marine bacteria, and fungi are the primary sources of Marine-derived Pharmaceuticals. The discovery of new anti-infectives to cater to the demand for new and efficacious antimicrobial compounds will support market growth during the forecast period.
The regular supply of marine organisms and compounds is challenging market growth. For example, sponges produce numerous bioactive metabolites, which serve as a chemical defense to combat environmental stress factors. One of the issues related to the supply of raw materials required for Marine-derived Pharmaceuticals is the non-availability of efficient technology for extraction. Moreover, the preservation of the compounds obtained is a challenge. Another hurdle is supply feasibility in an economical and eco-friendly manner. This makes it difficult to maintain a regular supply of marine-derived pharmaceutical compounds. Such factors will hinder market growth during the forecast period.
Marine-derived Pharmaceuticals Market Trends
- Drug Discovery from Deep-Sea Environments: Researchers were increasingly exploring deep-sea environments and extreme conditions for the discovery of novel marine-derived pharmaceutical compounds. These environments offer unique biodiversity and untapped potential for drug development.
- Marine microorganisms, such as bacteria and fungi, were gaining attention as sources of bioactive compounds with pharmaceutical potential. Researchers were isolating and characterizing compounds from these microorganisms for various medical Mode of Deliverys.
- Concerns about the environmental impact of marine biodiversity exploitation were leading to a greater focus on sustainable and ethical sourcing practices. Companies and researchers were exploring ways to harvest marine organisms responsibly.
- International collaboration and partnerships among research institutions, pharmaceutical companies, and marine conservation organizations were expanding the reach of marine-derived pharmaceutical research. Collaborations facilitated access to diverse marine ecosystems and resources.
- Several marine-derived pharmaceuticals advanced through clinical trials and received regulatory approvals for various medical indications, including cancer treatments, pain management, and antiviral drugs.
- Researchers were exploring marine-derived compounds for a broader range of medical Mode of Deliverys, including neurological disorders, anti-inflammatory agents, and cardiovascular therapies.
- The successful development and approval of marine-derived pharmaceuticals by regulatory agencies were bolstering confidence in the market and encouraging further research and investment.
- Some marine ecosystems were being leveraged for pharmaceutical research through responsible tourism initiatives, generating revenue for local economies while promoting marine conservation.
- The responsible sourcing of marine organisms for research and development was facing challenges related to seasonal availability, conservation, and adherence to ethical standards.
Competitive Landscape
The competitive landscape of the marine-derived pharmaceuticals market involves a range of players, including biotechnology companies, pharmaceutical firms, research institutions, and even some start-ups. This landscape is continually evolving as new discoveries are made, and as companies invest in research and development to bring marine-derived drugs to market.
- PharmaMar
- NUI Galway – Marine Biodiscovery Research Group
- Jazz Pharmaceuticals
- Aker Biomarine
- Prolong Pharmaceuticals
- Seattle Genetics
- OncoGenex Pharmaceuticals
- Marinomed Biotech
- Moleac
- Aquapharm
- Sirenas
- Giaconda Limited
- BioMarine
- Marinova
- Cyanea
- Scripps Institution of Oceanography
- OceanBASIS
- PharmaNautix
- Polynovo
- Sea Run Holdings
Recent Developments:
19 December 2019 – PharmaMar and Jazz Pharmaceuticals Ireland Limited have agreed to an exclusive license for lurbinectedin’s US market.
Regional Analysis
Asia Pacific accounted for the largest market in the Marine-derived Pharmaceuticals market. Asia Pacific accounted for the 40 % market share across the globe. Asia Pacific, mainly the United States and Canada, has a well-established and extensive network of research institutions, universities, and pharmaceutical companies that are actively engaged in marine-derived pharmaceutical research. These institutions have the expertise and resources to conduct in-depth studies and drug development. Government agencies and private organizations in Asia Pacific provide significant funding for marine pharmaceutical research. These investments support research initiatives and clinical trials, driving progress in the field.
Asia Pacific has a strong track record of advancing marine-derived pharmaceuticals through clinical trials and bringing them to market. The region is known for its expertise in the commercialization of such drugs. Several Asia Pacific pharmaceutical companies and biotechnology firms have successfully developed and commercialized marine-derived pharmaceutical products, which has bolstered the region’s leadership in the market. Asia Pacific pharmaceutical companies and biotechnology firms have effectively developed and commercialized marine-derived pharmaceutical products, which has bolstered the region’s leadership in the market.
Target Audience for Marine-derived Pharmaceuticals Market
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Pharmacologists and Medicinal Chemists
- Regulatory Agencies
- Clinical Researchers
- Bioprospecting Organizations
- Investors and Venture Capital Firms
- Marine Conservation Organizations
- Government Agencies
- Healthcare Providers
- Ethical and Sustainable Sourcing Initiatives
- Educational Institutions
- International Collaborations
Import & Export Data for Marine-derived Pharmaceuticals Market
Exactitude consultancy provides import and export data for the recent years. It also offers insights on production and consumption volume of the product. Understanding the import and export data is pivotal for any player in the Marine-derived Pharmaceuticals’ market. This knowledge equips businesses with strategic advantages, such as:
- Identifying emerging markets with untapped potential.
- Adapting supply chain strategies to optimize cost-efficiency and market responsiveness.
- Navigating competition by assessing major players’ trade dynamics.
Key insights
- Trade volume trends: our report dissects import and export data spanning the last five years to reveal crucial trends and growth patterns within the global Area Scan Camera Market. This data-driven exploration empowers readers with a deep understanding of the market’s trajectory.
- Market players: gain insights into the leading players driving the Surgical Drill trade. From established giants to emerging contenders, our analysis highlights the key contributors to the import and export landscape.
- Geographical dynamics: delve into the geographical distribution of trade activities. Uncover which regions dominate exports and which ones hold the reins on imports, painting a comprehensive picture of the industry’s global footprint.
- Product breakdown: by segmenting data based on Surgical Drill types –– we provide a granular view of trade preferences and shifts, enabling businesses to align strategies with the evolving technological landscape.
Import and export data is crucial in reports as it offers insights into global market trends, identifies emerging opportunities, and informs supply chain management. By analyzing trade flows, businesses can make informed decisions, manage risks, and tailor strategies to changing demand. This data aids governments in policy formulation and trade negotiations, while investors use it to assess market potential. Moreover, import and export data contributes to economic indicators, influences product innovation, and promotes transparency in international trade, making it an essential Mode of Delivery for comprehensive and informed analyses.
Segments Covered in the Marine-derived Pharmaceuticals Market Report
Marine-derived Pharmaceuticals Market by Type, 2020-2030, USD Â Million, (Kilotons)
- Phenol
- Steroid
- Ether
- Peptide
- Mollusk
- Sponge
- Tunicate
- Others
 Marine-derived Pharmaceuticals Market by Source 2020-2030, USD Million, (Kilotons)
- Algae
- Invertebrates
- Microorganisms
Marine-derived Pharmaceuticals Market by Mode of Delivery 2020-2030, USD Million, (Kilotons)
- Anti-microbial
- Anti-tumor
- Anti-cardiovascular
- Anti-viral
- Anti-inflammatory
- Others
Marine-derived Pharmaceuticals Market by End User, 2020-2030, USD Million, (Kilotons)
- Hospitals
- Retail Pharmacy
- Online Pharmacy
- Others
Marine-derived Pharmaceuticals Market by Region 2020-2030, USD Million, (Kilotons)
- Asia Pacific
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Key Question Answered
- what is the expected growth rate of the marine-derived pharmaceuticals market over the next 7 years?
- who are the major players in the marine-derived pharmaceuticals market and what is their market share?
- what are the end-user industries driving market demand and what is their outlook?
- what are the opportunities for growth in emerging markets such as asia-pacific, the middle east, and africa?
- how is the economic environment affecting the marine-derived pharmaceuticals market, including factors such as interest rates, inflation, and exchange rates?
- what is the expected impact of government policies and regulations on the marine-derived pharmaceuticals market?
- what is the current and forecasted size and growth rate of the marine-derived pharmaceuticals market?
- what are the key drivers of growth in the marine-derived pharmaceuticals market?
- who are the major players in the market and what is their market share?
- what are the distribution channels and supply chain dynamics in the marine-derived pharmaceuticals market?
- what are the technological advancements and innovations in the marine-derived pharmaceuticals market and their impact on product development and growth?
- what are the regulatory considerations and their impact on the market?
- what are the challenges faced by players in the marine-derived pharmaceuticals market and how are they addressing these challenges?
- what are the opportunities for growth and expansion in the marine-derived pharmaceuticals market?
- what are the product products and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- MARINE DERIVED PHARMACEUTICALS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON MARINE DERIVED PHARMACEUTICALS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- MARINE DERIVED PHARMACEUTICALS MARKET OUTLOOK
- GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE, 2020-2030, (USD MILLION) (KILOTONS)
- PHENOL
- STEROID
- ETHER
- PEPTIDE
- MOLLUSK
- SPONGE
- TUNICATE
- OTHERS
- GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE, 2020-2030, (USD MILLION) (KILOTONS)
- ALGAE
- INVERTEBRATES
- MICROORGANISMS
- GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY, 2020-2030, (USD MILLION) (KILOTONS)
- ANTI-MICROBIAL
- ANTI-TUMOR
- ANTI-CARDIOVASCULAR
- ANTI-VIRAL
- ANTI-INFLAMMATORY
- OTHERS
- GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER, 2020-2030, (USD MILLION) (KILOTONS)
- HOSPITALS
- RETAIL PHARMACY
- ONLINE PHARMACY
- OTHERS
- GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY REGION, 2020-2030, (USD MILLION) (KILOTONS)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- PHARMAMAR
- NUI GALWAY – MARINE BIODISCOVERY RESEARCH GROUP
- JAZZ PHARMACEUTICALS
- AKER BIOMARINE
- PROLONG PHARMACEUTICALS
- SEATTLE GENETICS
- ONCOGENEX PHARMACEUTICALS
- MARINOMED BIOTECH
- MOLEAC
- AQUAPHARM
- SIRENAS
- GIACONDA LIMITED
- BIOMARINE
- MARINOVA
- CYANEA
- SCRIPPS INSTITUTION OF OCEANOGRAPHY
- OCEANBASIS
- PHARMANAUTIX
- POLYNOVO
- SEA RUN HOLDINGS
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 2 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 3 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 4 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 5 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 6 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 7Â GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 8 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 9 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY REGION (USD MILLION) 2020-2030
TABLE 10 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY REGION (KILOTONS) 2020-2030
TABLE 11 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 12 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (KILOTONS) 2020-2030
TABLE 13 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-Â 2030
TABLE 14 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 15 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 16 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 17 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 18 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020- 2030
TABLE 19 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 20 NORTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 21 US MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 22 US MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 23 US MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 24 US MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 25 US MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 26 US MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 27 US MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 28 US MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 29 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 30 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 31 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 32 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 33 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 34 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 35 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 36 CANADA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 37 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 38 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 39 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 40 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 41 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 42 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 43 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 44 MEXICO MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 45 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 46 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (KILOTONS) 2020-2030
TABLE 47 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 48 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 49 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 50 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 51 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 52 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 53 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 54 SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 55 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 56 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 57 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 58 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 59 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 60 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 61 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 62 BRAZIL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 63 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 64 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 65 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 66 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 67 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 68 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 69 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 70 ARGENTINA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 71 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 72 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 73 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 74 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 75 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 76 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 77 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 78 COLOMBIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 79 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 80 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 81 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 82 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 83 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 84 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 85 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 86 REST OF SOUTH AMERICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 87 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 88 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (KILOTONS) 2020-2030
TABLE 89 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 90 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 91 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 92 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 93 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 94 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 95 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 96 ASIA-PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 97 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 98 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 99 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 100 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 101 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 102 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 103 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 104 INDIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 105 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 106 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 107 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 108 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 109 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 110 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 111 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 112 CHINA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 113 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 114 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 115 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 116 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 117 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 118 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 119 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 120 JAPAN MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 121 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 122 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 123 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 124 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 125 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 126 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 127 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 128 SOUTH KOREA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 129 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 130 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 131 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 132 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 133 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 134 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 135 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 136 AUSTRALIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 137 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 138 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 139 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 140 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 141 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 142 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 143 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 144 SOUTH-EAST ASIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 145 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 146 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 147 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 148 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 149 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 150 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 151 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 152 REST OF ASIA PACIFIC MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 153 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 154 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (KILOTONS) 2020-2030
TABLE 155 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 156 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 157 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 158 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 159 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 160 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 161 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 162 EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 163 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 164 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 165 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 166 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 167 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 168 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 169 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 170 GERMANY MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 171 UK MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 172 UK MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 173 UK MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 174 UK MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 175 UK MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 176 UK MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 177 UK MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 178 UK MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 179 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 180 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 181 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 182 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 183 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 184 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 185 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 186 FRANCE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 187 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 188 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 189 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 190 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 191 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 192 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 193 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 194 ITALY MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 195 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 196 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 197 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 198 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 199 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 200 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 201 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 202 SPAIN MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 203 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 204 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 205 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 206 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 207 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 208 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 209 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 210 RUSSIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 211 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 212 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 213 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 214 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 215 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 216 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 217 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 218 REST OF EUROPE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 219 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (USD MILLION) 2020-2030
TABLE 220 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY COUNTRY (KILOTONS) 2020-2030
TABLE 221 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 222 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 223 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 224 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 225 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 226 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 227 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 228 MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 229 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 230 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 231 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 232 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 233 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 234 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 235 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 236 UAE MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 237 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 238 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 239 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 240 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 241 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 242 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 243 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 244 SAUDI ARABIA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 245 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (USD MILLION) 2020-2030
TABLE 246 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 247 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 248 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 249 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 250 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 251 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 252 SOUTH AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
TABLE 253 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY VEHICLE Â TYPE (USD MILLION) 2020-2030
TABLE 254 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY (KILOTONS) 2020-2030
TABLE 255 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (USD MILLION) 2020-2030
TABLE 256 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY END USER (KILOTONS) 2020-2030
TABLE 257 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (USD MILLION) 2020-2030
TABLE 258 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE (KILOTONS) 2020-2030
TABLE 259 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (USD MILLION) 2020-2030
TABLE 260 REST OF MIDDLE EAST AND AFRICA MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE (KILOTONS) 2020-2030
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE USD MILLION, 2020-2030
FIGURE 9 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE USD MILLION, 2020-2030
FIGURE 10 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY,
USD MILLION, 2020-2030
FIGURE 11 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER, USD MILLION,
2020-2030
FIGURE 12 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY REGION, USD MILLION,
2020-2030
FIGURE 13 PORTER’S FIVE FORCES MODEL
FIGURE 14 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY TYPE USD MILLION, 2022
FIGURE 15 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY SOURCE, USD MILLION, 2022
FIGURE 16 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY MODE OF DELIVERY,
USD MILLION, 2022
FIGURE 17 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY END USER, USD MILLION, 2022
FIGURE 18 GLOBAL MARINE DERIVED PHARMACEUTICALS MARKET BY REGION, USD MILLION, 2022
FIGURE 19 MARKET SHARE ANALYSIS
FIGURE 20 ALSTOM: COMPANY SNAPSHOT
FIGURE 21 PHARMAMAR: COMPANY SNAPSHOT
FIGURE 22 NUI GALWAY – MARINE BIODISCOVERY RESEARCH GROUP: COMPANY SNAPSHOT
FIGURE 23 JAZZ PHARMACEUTICALS: COMPANY SNAPSHOT
FIGURE 24 AKER BIOMARINE: COMPANY SNAPSHOT
FIGURE 25 PROLONG PHARMACEUTICALS: COMPANY SNAPSHOT
FIGURE 26 SEATTLE GENETICS: COMPANY SNAPSHOT
FIGURE 27 ONCOGENEX PHARMACEUTICALS: COMPANY SNAPSHOT
FIGURE 28 MARINOMED BIOTECH: COMPANY SNAPSHOT
FIGURE 29 MOLEAC: COMPANY SNAPSHOT
FIGURE 30 AQUAPHARM: COMPANY SNAPSHOT
FIGURE 31 SIRENAS: COMPANY SNAPSHOT
FIGURE 32 GIACONDA LIMITED:COMPANY SNAPSHOT
FIGURE 33 BIOMARINE: COMPANY SNAPSHOT
FAQ
The global Marine-derived pharmaceuticals market is anticipated to grow from USD 2,922.11Â Million in 2023 to USD 5,341.16 Million by 2030, at a CAGR of 9.0 % during the forecast period.
Asia pacific accounted for the largest market in the Marine-derived Pharmaceuticals market. Asia pacific accounted for the 40 % market share across the globe.
PharmaMar, NUI Galway – Marine Biodiscovery Research Group, Jazz Pharmaceuticals, Aker Biomarine, Prolong Pharmaceuticals, Seattle Genetics, OncoGenex Pharmaceuticals, Marinomed Biotech, Moleac, Aquapharm, Sirenas
Researchers were increasingly exploring deep-sea environments and extreme conditions for the discovery of novel marine-derived pharmaceutical compounds. These environments offer unique biodiversity and untapped potential for drug development. Marine microorganisms, such as bacteria and fungi, were gaining attention as sources of bioactive compounds with pharmaceutical potential. Researchers were isolating and characterizing compounds from these microorganisms for various medical applications.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.